Skip to main content

Advertisement

SpringerLink
Log in

Cancer vaccines generated by photodynamic therapy

  • Perspective
  • Published:
Photochemical & Photobiological Sciences Aims and scope Submit manuscript

Abstract

The development of photodynamic therapy (PDT)-generated cancer vaccines is potentially one of the most significant achievements in the field of PDT. Employing vaccine protocols optimizes the capacity of PDT of inducing a strong immune response against treated tumor due to the establishment of highly favourable conditions for maximizing the avidity of the immune reaction while sustaining and prolonging its tumor-destroying attack. While the introduction of PDT vaccines into the clinics and testing on patients is still in a very early phase, much work can still be done on further improvement of the potency of PDT vaccines. Considerable advances can be expected by identifying the most effective adjuvants to be used with PDT vaccines, which will most likely be different with different types of cancerous lesions.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. L.A. Emens, Cancer vaccines: on the threshold of success, Expert Opin. Emerging Drugs, 2008, 13, 295–308.

    Article  CAS  Google Scholar 

  2. M. Vergati, C. Intrivici, N.-Y. Huen, J. Schlom and K. Y. Tsang, Strategies for cancer vaccine development, J. Biomed. Biotechnol., 2010, 2010, 596432.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. D. T. Le, D. M. Pardoll and E. M. Jaffee, Cellular vaccine approaches, Cancer J., 2010, 16, 304–310.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. S. Cecco, E. Muraro, E. Giacomin, D. Martorelli, R. Lazzarini, P. Baldo and R. Dolcetti, Cancer vaccines in Phase II/III clinical trials: state of the art and future perspectives, Curr. Cancer Drug Targets, 2011, 11, 85–102.

    Article  CAS  PubMed  Google Scholar 

  5. G. Canti, D. Lattuada, A. Nicolin, P. Taroni, G. Valentini and R. Cubeddu, Antitumorimmunity induced by photodynamic therapywith aluminium disulfonated phthalocyanines and laser light, Anti-Cancer Drugs, 1994, 5, 443–447.

    Article  CAS  PubMed  Google Scholar 

  6. M. Korbelik, Induction of tumor immunity by photodynamic therapy, J. Clin. Laser Med. Surg, 1996, 14, 329–334.

    Article  CAS  PubMed  Google Scholar 

  7. A. p. Castano, P. Mroz and M. R. Hamblin, Photodynamic therapy and anti-tumour immunity, Nat. Rev. Cancer, 2006, 6, 535–545.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. M. Korbelik, PDT-associated host response and its role in the therapy outcome, Lasers Surg. Med., 2006, 38, 500–508.

    Article  PubMed  Google Scholar 

  9. S. O. Gollnick and C. M. Brackett, Enhancement of anti-tumor immunity by photodynamic therapy, Immunol. Res., 2009, 46, 216–226.

    Article  CAS  Google Scholar 

  10. M. Korbelik, G. Krosl, J. Krosl and G. J. Dougherty, The role of host lymphoid populations in the response of mouse EMT6 tumors to photodynamic therapy, Cancer Res., 1996, 56, 5647–5652.

    CAS  PubMed  Google Scholar 

  11. M. Korbelik and I. Cecic, Contribution of myloid and lymphoid host cells to the curative outcome of mouse sarcoma treatment by photodynamic therapy, Cancer Lett., 1999, 137, 91–98.

    Article  CAS  PubMed  Google Scholar 

  12. P. C. Kousis, B. W. Henderson, P. G. Maier and S. O. Gollnick, Photodynamic therapy (PDT) enhancement of anti-tumor immunity is regulated by neutrophils, Cancer Res., 2007, 67, 10501–10510.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. S. O. Gollnick, B. Owczarczak and P. Maier, Photodynamic therapy and anti-tumor immunity, Lasers Surg. Med., 2006, 38, 509–515.

    Article  PubMed  Google Scholar 

  14. M. Korbelik, I. Cecic, S. Merchant and J. Sun, Acute phase response induction by cancer treatment with photodynamic therapy, Int. J. Cancer, 2007, 122, 1411–1417.

    Article  CAS  Google Scholar 

  15. S. Merchant, N. Huang and M. Korbelik, Expression of complement and pentraxin proteins in acute phase response elicited by tumor photodynamic therapy: the engagement of adrenal hormones, Int. Immunopharmacol., 2010, 10, 1595–1601.

    Article  CAS  PubMed  Google Scholar 

  16. I. Cecic, B. Stott, J. Sun and M. Korbelik, Relevance of innate immunity recognition of altered self in the induction of host response associated with photodynamic therapy, Recent Res. Devel. Cancer, 2004, 6, 153–161.

    CAS  Google Scholar 

  17. A. D. Garg, D. Nowis, J. Golab and P. Agostinis, Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity, Apoptosis, 2010, 15, 1050–1071.

    Article  CAS  PubMed  Google Scholar 

  18. S. O. Gollnick, L. A. Vaughan and B. W. Henderson, Gnereation of effective anti-tumor vaccines using photodynamic therapy, CancerRes., 2002, 62, 1604–1608.

    CAS  Google Scholar 

  19. M. Korbelik, and I. Cecic, Mechanism of tumor destruction by photodynamic therapy, in Handbook of Photochemistry and Photobiology, ed. H. S. Nalwa, American Scientific Publishers, Stevenson Ranch (California), 2003, vol. 4, ch. 2, pp. 39–77.

    CAS  Google Scholar 

  20. M. Korbelik and J. Sun, Photodynamic therapy-generated vaccine for cancer therapy, Cancer Immunol. Immunother., 2005, 55, 900–909.

    Article  PubMed  CAS  Google Scholar 

  21. D. Khurana, E. A. Martin, J. L. Kaspbauer, B. W. O’Malley, Jr., D. R. Salomao, L. Chen and S. E. Strome, Characterization of a spontaneously arising murine squamous cell carcinoma (SCC VII) as a prerequisite for head and neck cancer immunotherapy, Head Neck, 2001, 23, 899–906.

    Article  CAS  PubMed  Google Scholar 

  22. M. Korbelik, B. Stott and J. Sun, Photodynamic therapy-generated vaccines: relevance of tumour cell death expression, Br. J. Cancer, 2007, 97, 1381–1387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. M. Korbelik, S. Merchant and N. Huang, Explotation of immune response-eliciting properties of hypocrellin photosensitizer SL052-based photodynamic therapy for eradication of malignant tumors, Photochem. Photobiol., 2009, 85, 1418–1424.

    Article  CAS  PubMed  Google Scholar 

  24. S.-M. Bae, Y.-W. Kim, S.-Y. Kwak, Y.-W. Kim, D.-Y. Ro, J.-C. Shin, C.-H. Park, S.-J. Han, C.-H. Oh, C.-K. Kim and W.-S. Ahn, Photodynamic therapy-generated tumor cell lysates with CpG-oligodeoxynucleotide enhance immunotherapy efficacy in human papillomavirus 16 (E6/E7) immortalized tumor cells, Cancer Sci., 2007, 98, 747–752.

    Article  CAS  PubMed  Google Scholar 

  25. H. Zhang, W. Ma and Y. Li, Generation of effective vaccines against liver cancer by using photodynamic therapy, Lasers Med. Sci., 2008, 24, 549–552.

    Article  PubMed  Google Scholar 

  26. T. Kushibiki, T. Tajiri, Y. Tamioka and K. Awazu, Photodynamic therapy induces interleukin secretion from dendritic cells, Int. J. Clin. Exp. Med., 2010, 3, 110–114.

    CAS  PubMed  PubMed Central  Google Scholar 

  27. M. Korbelik and J. Sun, Progress in the development of phtodynamic therapy-generated cancer vaccines, Proc. SPIE–Int. Soc. Opt. Eng., 2003, 4961, 10–17.

    Google Scholar 

  28. J. M. Critchfield, M. K. Racke, J. C. Zuniga-Pflucker, B. Cannella, C. S. Raine, J. Goverman and M. J. Lenardo, T cell depletion in high antigen dose therapy of automimmune encephalomyelitis, Science, 1994, 263, 1139–1143.

    Article  CAS  PubMed  Google Scholar 

  29. J. Friedberg, A photodynamic therapy generated tumor vaccine in an orthotopic murine malignant mesothelioma model, presented in part at the 8th International Conference of the International Mesothelioma Inetrest Group, Chicago, October, 2006.

  30. M. Korbelik, Photodynamic therapy-generated cancer vaccines, Methods Mol. Biol., 2010, 635, 147–153.

    Article  CAS  PubMed  Google Scholar 

  31. C. J. Gomer, S. W. Ryter, A. Ferrario, N. Rucker, S. Wong and A. M. R. Fisher, Photodynamic therapy-mediated oxidative stress can induce expression of heat shock proteins, Cancer Res., 1996, 56, 2355–2360.

    CAS  PubMed  Google Scholar 

  32. M. Korbelik, J. Sun and I. Cecic, Photodynamic therapy-induced cell surface expression and release of heat shock proteins: relevance for tumor response, Cancer Res., 2005, 65, 1018–1026.

    CAS  PubMed  Google Scholar 

  33. F. Zhou, D. Xing and W. R. Chen, Regulation of HSP70 on activating macrophages using PDT-induced apoptotic cells, Int. J. Cancer, 2009, 125, 1380–1389.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. S. O. Gollnick, E. Kabingu, P. C. Kousis and B. W. Henderson, Stimulation of host immune response by photodynamci therapy (PDT), Proc. SPIE–Int. Soc. Opt. Eng., 2004, 5319, 60–70.

    CAS  Google Scholar 

  35. M. Korbelik, PDT-generated cancer vaccines, Photodiagnosis Photodyn. Ther., 2008, 5, 71.

    Google Scholar 

  36. S. Merchant and M. Korbelik, Heat shock protein 70 is acute phase reactant: response elicited by tumor treatment with photodynamic therapy, Cell Stress Chaperones, DOI: 10.1007/s12192-010-0227-5.

  37. B. Javid, P. A. MacAry, W. Oehlmann, M. Singh and P. J. Lehner, Peptides complexed with the protein HSP70 generate efficient human cytolytic T-lymphocyte response, Biochem. Soc. Trans., 2004, 32, 622–625.

    Article  CAS  PubMed  Google Scholar 

  38. L. Cannarile, O. Zollo, F. D’Adamio, E. Ayroldi, C. Marchetti, A. Tabilio, S. Brucoli and C. Riccardi, Cloning, chromosomal assignement and tissue distribution of human GILZ, a gluococrticoid hormoneinduced gene, Cell Death Differ., 2001, 8, 201–203.

    Article  CAS  PubMed  Google Scholar 

  39. S. Saho, D. R. Brickley, M. Kocherginsky and S. D. Conzen, Coordinate expression of the PI2-kinase downstream effectors serum- and glucocorticoid-induced kinase (SGK-1) and Akt-1 in human breast cancer, Eur. J. Cancer, 2005, 41, 2754–2759.

    Article  CAS  Google Scholar 

  40. A. M. de Chatelineau and P. M. Henson, The final step in programmed cell death: phagocytes carry apoptotic cells tot the grave, Essays Biochem., 2003, 13, 648–656.

    Google Scholar 

  41. G. Majai, G. Petrovski and L. Fesus, Inflammation and the apopto-phagocytic system, Immunol. Lett., 2006, 104, 94–101.

    Article  CAS  PubMed  Google Scholar 

  42. A. Heisler, M. A. Maurice, D. R. Yancey, D. M. Coleman, P. Dahm and J. Vieweg, Human dendritic cells transfected with renal tumor RNA stimulate polyclonal T-cell response against antigens expressed by primary and metastatic tumors, Cancer Res., 2001, 61, 3388–3393.

    Google Scholar 

  43. S.O. Gollnick, A. Mazzacua, L. Vaughan, B. Owczarczak, P. Maier and B. W. Henderson, Photodynamic therapy (PDT) treatment enhances tumor cell antigenicity, Proc. SPIE–Int. Soc. Opt. Eng., 2001, 4257, 25–28.

    CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. British Columbia Cancer Agency, Vancouver, BC, Canada

    Mladen Korbelik

Authors
  1. Mladen Korbelik
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mladen Korbelik.

Additional information

This article is published as part of a themed issue on immunological aspects and drug delivery technologies in PDT.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Korbelik, M. Cancer vaccines generated by photodynamic therapy. Photochem Photobiol Sci 10, 664–669 (2011). https://doi.org/10.1039/c0pp00343c

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1039/c0pp00343c

Search

Navigation